These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29087405)

  • 1.
    Liu M; Liu S
    Dalton Trans; 2017 Oct; 46(42):14509-14518. PubMed ID: 29087405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of boronate capping groups on biological characteristics of novel (99m)Tc(III) complexes [(99m)TcCl(CDO)(CDOH)2B-R] (CDOH2 = cyclohexanedione dioxime).
    Yang Y; Zheng Y; Tomaselli E; Fang W; Liu S
    Bioconjug Chem; 2015 Feb; 26(2):316-28. PubMed ID: 25585053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel
    Liu M; Fang W; Liu S
    Bioconjug Chem; 2016 Nov; 27(11):2770-2779. PubMed ID: 27737549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel
    Liu M; Zheng Y; Avcibasi U; Liu S
    Nucl Med Biol; 2016 Nov; 43(11):732-741. PubMed ID: 27632344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of co-ligands on chemical and biological properties of (99m)Tc(III) complexes [(99m)Tc(L)(CDO)(CDOH)2BMe] (L=Cl, F, SCN and N3; CDOH2=cyclohexanedione dioxime).
    Zheng Y; Ji S; Tomaselli E; Ernest C; Freiji T; Liu S
    Nucl Med Biol; 2014; 41(10):813-24. PubMed ID: 25169135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfonyl-Containing Boronate Caps for Optimization of Biological Properties of
    Zhao ZQ; Liu M; Fang W; Liu S
    J Med Chem; 2018 Jan; 61(1):319-328. PubMed ID: 29186661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Approach for
    Liu M; Zhao ZQ; Fang W; Liu S
    Bioconjug Chem; 2017 Dec; 28(12):2998-3006. PubMed ID: 29148726
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Xi XY; Wang L; Hsu B; Zhao ZQ; Liu S; Fang W
    J Nucl Cardiol; 2021 Dec; 28(6):2687-2696. PubMed ID: 32180138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neutral technetium-99m complex for myocardial imaging.
    Narra RK; Nunn AD; Kuczynski BL; Feld T; Wedeking P; Eckelman WC
    J Nucl Med; 1989 Nov; 30(11):1830-7. PubMed ID: 2809747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of novel cationic (99m)Tc-nitrido complexes as radiopharmaceuticals for heart imaging: improving liver clearance with crown ether groups.
    Liu S; He Z; Hsieh WY; Kim YS
    Nucl Med Biol; 2006 Apr; 33(3):419-32. PubMed ID: 16631092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion.
    Beanlands RS; DeKemp RA; Harmsen E; Veinot JP; Hartman NG; Ruddy TD
    J Am Coll Cardiol; 1996 Aug; 28(2):487-94. PubMed ID: 8800130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary report of SPECT imaging with Tc-99m teboroxime in ischemic heart disease.
    Drane WE; Keim S; Strickland P; Tineo A; Nicole M
    Clin Nucl Med; 1992 Mar; 17(3):215-25. PubMed ID: 1611794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kit formulated asialoglycoprotein receptor targeting tracer based on copolymer for liver SPECT imaging.
    Liu C; Guo Z; Zhang P; Song M; Zhao Z; Wu X; Zhang X
    Nucl Med Biol; 2014 Aug; 41(7):587-93. PubMed ID: 24815356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and Preliminary Evaluation of a Promising
    Fang Y; Li Y; Liang H; Li W; Zhang H
    J Med Chem; 2023 Mar; 66(6):3953-3967. PubMed ID: 36950862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New
    Fang W; Liu S
    Curr Radiopharm; 2019; 12(3):171-186. PubMed ID: 30727939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid hepatic clearance of 99mTc-TMEOP: a new candidate for myocardial perfusion imaging.
    Goethals LR; Santos I; Caveliers V; Paulo A; De Geeter F; Lurdes PG; Fernandes C; Lahoutte T
    Contrast Media Mol Imaging; 2011; 6(4):178-88. PubMed ID: 21861278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
    Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
    J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of novel cationic 99mTc(I)-tricarbonyl complexes as potential radiotracers for myocardial perfusion imaging.
    He Z; Hsieh WY; Kim YS; Liu S
    Nucl Med Biol; 2006 Nov; 33(8):1045-53. PubMed ID: 17127179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with technetium-99m teboroxime, a neutral, lipophilic myocardial perfusion imaging agent.
    Johnson LL; Seldin DW
    Am J Cardiol; 1990 Oct; 66(13):63E-67E. PubMed ID: 2220625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics.
    Shi J; Wang L; Kim YS; Zhai S; Jia B; Wang F; Liu S
    Eur J Nucl Med Mol Imaging; 2009 Nov; 36(11):1874-84. PubMed ID: 19484236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.